Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection.
about
Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonistsDPP4 deficiency preserved cardiac function in abdominal aortic banding ratsStimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium.PEGylated exendin-4, a modified GLP-1 analog exhibits more potent cardioprotection than its unmodified parent molecule on a dose to dose basis in a murine model of myocardial infarction.Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes - a randomized, single-blinded, cross-over pilot study.Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice.Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitusChanges in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients.GLP-1: benefits beyond pancreas.AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes.Glucagon-like peptide-1 receptor antagonism impairs basal exercise capacity and vascular adaptation to aerobic exercise training in rats.
P2860
Q26823085-9C254546-E199-462D-8002-0A62B28E4497Q28538591-9E4771C9-37CF-4B3E-877F-2654F7F9D7CCQ34355984-D88FAEF4-E191-4431-B06B-D5B2A16BB41FQ34785887-704602CA-C019-4878-85A5-1EE0ED7ED057Q35532329-FACC0087-6515-4EE2-9452-93D18D5CCD77Q35922922-A12C4D58-6163-4518-8AB5-EA972A5C618BQ35926588-21411711-2DD3-46DB-AF7E-4D7663E00A0FQ37581317-2F815DCE-D836-45E7-9706-3D09A38893F6Q38238288-73E5DF82-A23C-435A-85C3-FD387C787A24Q46851623-0985C14F-CB22-4075-BC11-CD436914109CQ55618567-50D9E467-CF75-48DF-A777-AF6A93FFA6A3
P2860
Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Glucagon-like peptide-1 (GLP-1 ...... ach for myocardial protection.
@en
type
label
Glucagon-like peptide-1 (GLP-1 ...... ach for myocardial protection.
@en
prefLabel
Glucagon-like peptide-1 (GLP-1 ...... ach for myocardial protection.
@en
P2860
P921
P356
P1476
Glucagon-like peptide-1 (GLP-1 ...... ach for myocardial protection.
@en
P2093
Ting C Zhao
P2860
P2888
P356
10.1186/1475-2840-12-90
P407
P5008
P577
2013-06-18T00:00:00Z
P5875
P6179
1027923830